|
1) Galié N, Hoeper MM, Humbert M. Guidelines for the diagnosis and treatment of pulmonary hypertension. Euro Heart J. 2009; 30: 2493–537
|
|
|
|
|
2) Gllie N, Kim NHS, et al. Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006; 3: 571-6
|
|
|
|
|
3) Galie N, Kim NH. Pulmonary microvascular disease in CTEPH. Proc Am Thorac Soc. 2006; 3: 571-6
|
|
|
|
|
|
4) Hoeper MM, Mayer E, Simonneauet G, et al. Chronic thromboembolic pulmonary hypertension. Circulation. 2006; 113: 2011-20
|
|
|
|
|
|
5) http://www.mhlw.go.jp/toukei/index.html. 平成21年度衛生行政報告例結果の概要 特定疾患医療受給者証所持者数
|
|
|
|
|
|
6) Keogh AM, Mayer E, Benza RL. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol. 2009; 54: 67-77
|
|
|
|
|
|
7) Auger WR, Kerr KM, Kim NH, et al. Chronic thromboembolic pulmonary hypertension. Cardiol Clin. 2004; 22: 453–66
|
|
|
|
|
|
8) Riedel M, Stanek V, Widimsky J, et al. Long term follow-up of patients with pulmonary thromboembolism: late prognosisand evolution of hemodynamic and respiratory data. Chest. 1982; 81: 151-8
|
|
|
|
|
|
9) 中西宣文, 京谷晋吾, 佐藤 徹, 他. 慢性肺血栓塞栓症例の肺血行動態と長期予後に関する検討. 日胸疾会誌. 1997; 35: 589-95
|
|
|
|
|
10) Ono F, Nagaya N, Okumura H, et al. Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction. Chest. 2003; 123; 1583-8
|
|
|
|
|
|
11) Jaïs X, D'Armini AM, Jansa P, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension. BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008; 52: 2127–34
|
|
|
|
|
|
12) Suntharalingam J, Treacy CM, Doughty NJ, et al. Long term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest. 2008; 134: 229–36
|
|
|
|
|
|
13) Reichenberger F, Voswinckel R, Enke B, et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2007; 30: 922–7
|
|
|
|
|
|
14) Feinstein JA, Goldhaber SZ, Lock JE, et al. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001; 103: 10-3
|
|
|
|
|
|
15) 三重野龍彦, 青木茂行, 管間康夫, 他. 肺血栓塞栓症1. 本邦における肺血栓塞栓症の疫学的検討(日本病理剖検輯報に基づいて). 日胸疾会誌. 1988; 26: 448-56
|
|
|
|
|
|
16) Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation. 1990; 81: 1735-42
|
|
|
|
|
|
17) Pengo V, Lensing AWA, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004; 350: 2257-64
|
|
|
|
|
|
18) 田辺信宏, 岡田 修, 巽浩一郎, 他. 呼吸不全6疾患の全国疫学調査. わが国における慢性血栓塞栓性肺高血圧症の検討. 厚生省特定疾患呼吸器系疾患調査研究班呼吸不全調査研究班平成9年度研究報告書. 1998: 129-31
|
|
|
|
|
|
19) Thistlethwaite PA, Mo M, Madani MM, et al. Ope- rative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg. 2002; 124: 1203-11
|
|
|
|
|
|
20) Fedullo PF, Auger WR, Kerr KM, et al. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2001; 345: 1465–72
|
|
|
|
|
|
21) Klepetko W, Kapelanski DP, Sakakibara N, et al. Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol. 2004; 43(suppl S): 73S–80S
|
|
|
|
|
|
22) Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary end arterectomy: experience and lessons learned in 1, 500 cases. Ann Thorac Surg. 2003; 76: 1457–62; discussion 1462–54
|
|
|
|
|
|
23) Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004; 23: 637–48
|
|
|
|
|